Vance Street Capital has hired John LeRosen as the firm’s newest Vice President. Mr. LeRosen’s duties will be to source and close transactions as well as to work with portfolio company management teams.
“I am thrilled to be joining Vance Street Capital,” said Mr. LeRosen. “Vance Street provides management teams with a level of support and industry insight rarely found in the middle market. I look forward to working closely with the firm’s talented team of investors and business operators.”
Prior to joining Vance Street Capital, Mr. LeRosen served as Chief Financial Officer of Avalon Laboratories, a manufacturer of specialty medical tubing, from November 2009 to June 2015. Avalon Laboratories was acquired by Nordson Corporation in August 2014. Before his time at Avalon, he was with American Capital and was part of the team that made an investment in Avalon in January 2008.
Mr. LeRosen spent eight years at American Capital where he focused on investing and providing financial due diligence support across dozens of companies in medical components and devices, specialty manufacturing, life sciences and industrial technology sectors. He began his career at KPMG and has a Bachelor of Business Administration degree with an emphasis in Accounting from James Madison University.
“We’ve known John for many years and are very pleased that he is joining Vance Street,” said Richard Crowell, Managing Partner. “John brings a wealth of operational knowledge and deal experience that will prove invaluable as Vance Street continues to grow its portfolio. In particular, John’s insights on the precision medical component industry, both as a former CFO and an investor in precision medical components companies, will greatly benefit our existing and future portfolio companies.”
Vance Street Capital makes control investments in companies with enterprise values up to $200 million. Sectors of interest include general industrial, aerospace & defense, and medical components and devices. The firm is based in Los Angeles (www.vancestreetcapital.com).
© 2015 PEPD • Private Equity’s Leading News Magazine • 8-11-15